Bisulfite conversion of DNA: Performance comparison of different kits and methylation quantitation of epigenetic biomarkers that have the potential to be used in non-invasive prenatal testing

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Leontiou, Chrysanthia A ^a   Hadjidaniel, Michael D ^a   Mina, Petros ^a   Antoniou, Pavlos ^b   Ioannides, Marios ^a   Patsalis, Philippos C ^a,c  

^a CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^b NIPD Genetics Ltd   (Cyprus)

^c NICOSIA GENERAL HOSPITAL   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA; DIAGNOSTIC KIT; HYDROGEN SULFITE; SULFITE;

AMPLICON; ANALYTIC METHOD; ARTICLE; BISULFITE CONVERSION; BISULFITE CONVERSION KIT; BLOOD SAMPLING; CHORION VILLUS; CONTROLLED STUDY; DIAGNOSTIC KIT; DNA DEGRADATION; DNA DETERMINATION; DNA METHYLATION; EPIGENETICS; GENE SEQUENCE; HUMAN; NEXT GENERATION SEQUENCING; NON INVASIVE MEASUREMENT; PRENATAL DIAGNOSIS; CHEMISTRY; COMPARATIVE STUDY; CPG ISLAND; DNA DENATURATION; GENETIC EPIGENESIS; HIGH THROUGHPUT SEQUENCING; HUMAN GENOME; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; STANDARDS;

BASE SEQUENCE; CHORIONIC VILLI; CPG ISLANDS; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID DENATURATION; PRENATAL DIAGNOSIS; REAGENT KITS, DIAGNOSTIC; SULFITES;

EID: 84942155057     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135058     Document Type: Article

References (54)

1. Grimshaw G, Szczepura A, Hultén M, MacDonald F, Nevin N, Sutton F, et al. Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. Health Technology Assessment. 2003; 7 (10). PMID: 12773259
2. Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. Advances in experimental medicine and biology. 2010; 686:349-64. Epub 2010/09/09. doi: 10.1007/978-90-481-9485-8-20 PMID: 20824455.
3. Driscoll DA, Gross S. Clinical practice. Prenatal screening for aneuploidy. N Engl J Med. 2009; 360 (24):2556-62. Epub 2009/06/12. 360/24/2556 [pii]doi: 10.1056/NEJMcp0900134 PMID: 19516035.
4. Papageorgiou EA, Patsalis PC. Non-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications. Genome Med. 2012; 4(5):46. Epub 2012/05/30. doi: 10.1186/gm345gm345 [pii]. PMID: 22640877; PubMed Central PMCID: PMC3506912.
5. Wapner RJ. Invasive prenatal diagnostic techniques. Semin Perinatol. 2005; 29(6):401-4. PMID: 16533654.
6. Valenti C, Schutta EJ, Kehaty T. Prenatal diagnosis of Down's syndrome. Lancet. 1968; 2(7561):220. PMID: 4173436.
7. Evans MI, Wapner RJ. Invasive prenatal diagnostic procedures 2005. Semin Perinatol. 2005; 29 (4):215-8. Epub 2005/08/18. doi: 10.1053/j.semperi.2005.06.004 PMID: 16104671.
8. Haraldsdottir KR, Gottfredsdottir H, Geirsson RT. [Fetal loss after amniocentesis and chorionic villus sampling in Iceland]. Laeknabladid. 2014; 100(3):147-51. Epub 2014/03/19. PMID: 24636902.
9. Theodora M, Antsaklis A, Blanas K, Antsaklis P, Daskalakis G, Sindos M, et al. Risk for fetal loss and prematurity after 12,413 second trimester amniocenteses in a single center. Journal of perinatal medicine. 2014. Epub 2014/12/09. doi: 10.1515/jpm-2014-0236 PMID: 25485612.
10. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997; 350(9076):485-7. Epub 1997/08/16. S0140-6736(97) 02174-0 [pii] doi: 10.1016/S0140-6736(97)02174-0 PMID: 9274585.
11. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. American journal of human genetics. 1998; 62(4):768-75. Epub 1998/06/13. doi: 10.1086/301800 PMID: 9529358; PubMed Central PMCID: PMC1377040.
12. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. American journal of human genetics. 1999; 64(1):218-24. PMID: 9915961.
13. Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. American journal of human genetics. 1997; 61(4):822-9. Epub 1997/10/23. S0002-9297(07)64189-5 [pii]doi: 10.1086/514885 PMID: 9382092; PubMed Central PMCID: PMC1715976.
14. Hudecova I, Sahota D, Heung MM, Jin Y, Lee WS, Leung TY, et al. Maternal plasma fetal DNA fractions in pregnancies with low and high risks for fetal chromosomal aneuploidies. PloS one. 2014; 9(2): e88484. Epub 2014/03/04. doi: 10.1371/journal.pone.0088484 PMID: 24586333; PubMed Central PMCID: PMC3938419.
15. Pertl B, Sekizawa A, Samura O, Orescovic I, Rahaim PT, Bianchi DW. Detection of male and female fetal DNA in maternal plasma by multiplex fluorescent polymerase chain reaction amplification of short tandem repeats. Hum Genet. 2000; 106(1):45-9. Epub 2000/09/12. PMID: 10982181.
16. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clinical chemistry. 1999; 45(2):184-8. Epub 1999/02/04. PMID: 9931039.
17. Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet. 2000; 356(9236):1170. PMID: 11030304.
18. Tang NL, Leung TN, Zhang J, Lau TK, Lo YM. Detection of fetal-derived paternally inherited X-chromosome polymorphisms in maternal plasma. Clinical chemistry. 1999; 45(11):2033-5. Epub 1999/11/02. PMID: 10545084.
19. Tsui DW, Chiu RW, Lo YD. Epigenetic approaches for the detection of fetal DNA in maternal plasma. Chimerism. 2010; 1(1):30-5. Epub 2011/02/18. doi: 10.4161/chim.1.1.12439 PMID: 21327153; PubMed Central PMCID: PMC3035115.
20. Wolffe AP, Matzke MA. Epigenetics: regulation through repression. Science. 1999; 286(5439):481-6. Epub 1999/10/16. PMID: 10521337.
21. Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science. 2001; 293 (5532):1068-70. Epub 2001/08/11. doi: 10.1126/science.1063852 PMID: 11498573.
22. Poon LL, Leung TN, Lau TK, Chow KC, Lo YM. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clinical chemistry. 2002; 48(1):35-41. Epub 2001/12/26. PMID: 11751536.
23. Papageorgiou EA, Fiegler H, Rakyan V, Beck S, Hulten M, Lamnissou K, et al. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol. 2009; 174(5):1609-18. PMID: 19349366. doi: 10.2353/ajpath. 2009.081038
24. Tong YK, Jin S, Chiu RW, Ding C, Chan KC, Leung TY, et al. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clinical chemistry. 2010; 56(1):90-8. Epub 2009/10/24. doi: 10.1373/clinchem.2009.134114 PMID: 19850629.
25. Chim SS, Jin S, Lee TY, Lun FM, Lee WS, Chan LY, et al. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clinical chemistry. 2008; 54(3):500-11. Epub 2008/01/19. clinchem.2007.098731 [pii] doi: 10.1373/clinchem.2007.098731 PMID: 18202156.
26. Old RW, Crea F, Puszyk W, Hulten MA. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Reprod Biomed Online. 2007; 15(2):227-35. Epub 2007/08/19. PMID: 17697502.
27. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proceedings of the National Academy of Sciences of the United States of America. 1992; 89(5):1827-31. Epub 1992/03/01. PMID: 1542678; PubMed Central PMCID: PMC48546.
28. Grunau C, Clark SJ, Rosenthal A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic acids research. 2001; 29(13):E65-5. PMID: 11433041.
29. Li Y, Tollefsbol TO. DNA methylation detection: bisulfite genomic sequencing analysis. Methods in molecular biology. 2011; 791:11-21. Epub 2011/09/14. doi: 10.1007/978-1-61779-316-5-2 PMID: 21913068; PubMed Central PMCID: PMC3233226.
30. Lun FM, Chiu RW, Sun K, Leung TY, Jiang P, Chan KC, et al. Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA. Clinical chemistry. 2013; 59 (11):1583-94. Epub 2013/07/17. doi: 10.1373/clinchem.2013.212274 PMID: 23857673.
31. Chiu RW, Chim SS, Wong IH, Wong CS, Lee WS, To KF, et al. Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol. 2007; 170(3):941-50. PMID: 17322379.
32. Tong YK, Chiu RW, Akolekar R, Leung TY, Lau TK, Nicolaides KH, et al. Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker. PloS one. 2010; 5(12):e15244. Epub 2011/01/21. doi: 10.1371/journal.pone.0015244 PMID: 21249119; PubMed Central PMCID: PMC3004793.
33. Ehrich M, Zoll S, Sur S, van den Boom D. A new method for accurate assessment of DNA quality after bisulfite treatment. Nucleic acids research. 2007; 35(5):e29. Epub 2007/01/30. doi: 10.1093/nar/gkl1134 PMID: 17259213; PubMed Central PMCID: PMC1865059.
34. Lewin J, Schmitt AO, Adorjan P, Hildmann T, Piepenbrock C. Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics. 2004; 20 (17):3005-12. Epub 2004/07/13. doi: 10.1093/bioinformatics/bth346 PMID: 15247106.
35. Xi Y, Li W. BSMAP: whole genome bisulfite sequence MAPping program. BMC Bioinformatics. 2009; 10:232. Epub 2009/07/29. doi: 10.1186/1471-2105-10-232 PMID: 19635165; PubMed Central PMCID: PMC2724425.
36. Warnecke PM, Stirzaker C, Melki JR, Millar DS, Paul CL, Clark SJ. Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. Nucleic acids research. 1997; 25(21):4422-6. Epub 1997/10/23. PMID: 9336479; PubMed Central PMCID: PMC147052.
37. Deng J, Shoemaker R, Xie B, Gore A, LeProust EM, Antosiewicz-Bourget J, et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol. 2009; 27(4):353-60. Epub 2009/03/31. doi: 10.1038/nbt.1530 PMID: 19330000; PubMed Central PMCID: PMC2715272.
38. Wang J, Jiang H, Ji G, Gao F, Wu M, Sun J, et al. High resolution profiling of human exon methylation by liquid hybridization capture-based bisulfite sequencing. BMC Genomics. 2011; 12:597. Epub 2011/12/14. doi: 10.1186/1471-2164-12-597 PMID: 22151801; PubMed Central PMCID: PMC3295804.
39. Lee EJ, Pei L, Srivastava G, Joshi T, Kushwaha G, Choi JH, et al. Targeted bisulfite sequencing by solution hybrid selection and massively parallel sequencing. Nucleic acids research. 2011; 39(19): e127. Epub 2011/07/26. doi: 10.1093/nar/gkr598 PMID: 21785137; PubMed Central PMCID: PMC3201883.
40. Ivanov M, Kals M, Kacevska M, Metspalu A, Ingelman-Sundberg M, Milani L. In-solution hybrid capture of bisulfite-converted DNA for targeted bisulfite sequencing of 174 ADME genes. Nucleic acids research. 2013; 41(6):e72. Epub 2013/01/18. doi: 10.1093/nar/gks1467 PMID: 23325842; PubMed Central PMCID: PMC3616706.
41. Masser DR, Berg AS, Freeman WM. Focused, high accuracy 5-methylcytosine quantitation with base resolution by benchtop next-generation sequencing. Epigenetics & chromatin. 2013; 6(1):33. Epub 2013/11/28. doi: 10.1186/1756-8935-6-33 PMID: 24279302; PubMed Central PMCID: PMC3907040.
42. Raizis AM, Schmitt F, Jost JP. A bisulfite method of 5-methylcytosine mapping that minimizes template degradation. Anal Biochem. 1995; 226(1):161-6. Epub 1995/03/20. doi: 10.1006/abio.1995.1204 PMID: 7785768.
43. Zhang Y, Jeltsch A. The application of next generation sequencing in DNA methylation analysis. Genes (Basel). 2010; 1(1):85-101. Epub 2010/01/01. doi: 10.3390/genes1010085 PMID: 24710012; PubMed Central PMCID: PMC3960863.
44. Genereux DP, Johnson WC, Burden AF, Stoger R, Laird CD. Errors in the bisulfite conversion of DNA: modulating inappropriate-And failed-conversion frequencies. Nucleic acids research. 2008; 36(22): e150. Epub 2008/11/06. doi: 10.1093/nar/gkn691 PMID: 18984622; PubMed Central PMCID: PMC2602783.
45. Rohde C, Zhang Y, Reinhardt R, Jeltsch A. BISMA-fast and accurate bisulfite sequencing data analysis of individual clones from unique and repetitive sequences. BMC Bioinformatics. 2010; 11:230. Epub 2010/05/13. doi: 10.1186/1471-2105-11-230 PMID: 20459626; PubMed Central PMCID: PMC2877691.
46. Biosystems A. Methylation Analysis by Bisulfite Sequencing: Chemistry, Products and Protocols from Applied Biosystems 2007.
47. Tost J. Epigenetics. Norfolk, UK: Caister Academic Press; 2008.
48. Papageorgiou EA, Karagrigoriou A, Tsaliki E, Velissariou V, Carter NP, Patsalis PC. Fetal specific DNA methylation ratio permits non-invasive prenatal diagnosis of trisomy 21. Nature Medicine. 2011; 17:510-3. doi: 10.1038/nm.2312 PMID: 21378977
49. Lim JH, Lee da E, Park SY, Kim do J, Ahn HK, Han YJ, et al. Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21. BMC Med Genomics. 2014; 7:1. Epub 2014/01/09. doi: 10.1186/1755-8794-7-1 PMID: 24397966; PubMed Central PMCID: PMC3892082.
50. Fuso A, Ferraguti G, Scarpa S, Ferrer I, Lucarelli M. Disclosing bias in bisulfite assay: MethPrimers underestimate high DNA methylation. PloS one. 2015; 10(2):e0118318. Epub 2015/02/19. doi: 10. 1371/journal.pone.0118318 PMID: 25692551; PubMed Central PMCID: PMC4333220.
51. Allhoff M, Schonhuth A, Martin M, Costa IG, Rahmann S, Marschall T. Discovering motifs that induce sequencing errors. BMC Bioinformatics. 2013; 14 Suppl 5:S1. Epub 2013/06/14. doi: 10.1186/1471-2105-14-S5-S1 PMID: 23735080; PubMed Central PMCID: PMC3622629.
52. Sun S, Noviski A, Yu X. MethyQA: a pipeline for bisulfite-treated methylation sequencing quality assessment. BMC Bioinformatics. 2013; 14:259. Epub 2013/08/24. doi: 10.1186/1471-2105-14-259 PMID: 23968174; PubMed Central PMCID: PMC3765750.
53. Laird PW. Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet. 2010; 11(3):191-203. Epub 2010/02/04. doi: 10.1038/nrg2732nrg2732 [pii]. PMID: 20125086.
54. Holmes EE, Jung M, Meller S, Leisse A, Sailer V, Zech J, et al. Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine. PloS one. 2014; 9(4):e93933. Epub 2014/04/05. doi: 10.1371/journal.pone.0093933 PMID: 24699908; PubMed Central PMCID: PMC3974851.